{"disease":{"id":"graft-versus-host-disease-prevention","name":"graft versus host disease prevention"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04014790","title":"RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Regimmune Corporation","has_results":true},{"nct_id":"NCT04686929","title":"Abatacept s.c. for aGVHD Prevention in Haplo-HCT","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03862079","title":"Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}